0 TSX Venture News - January 13, 2020Tetra Bio-Pharma Receives Favorable Letter of Advice from USA FDA for QIXLEEFFDA Feedback continues to support the development of QIXLEEF for second- or third-line therapy for adult patients with uncontrolled painFDA […]Read More
0 TSX Venture News - January 13, 2020IntelGenx Provides Commercial Update on its Two Lead VersaFilm® Product Candidates, Cannabis-Infused Oral Film and RIZAPORT®SAINT LAURENT, Quebec, Jan. 13, 2020 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today […]Read More
0 TSX Venture News - January 13, 2020British Columbia Securities Commission Dismisses Complaint Regarding Titan Minerals Take-Over OfferVANCOUVER, British Columbia, Jan. 13, 2020 (GLOBE NEWSWIRE) — Core Gold Inc. (“Core Gold” or the “Company“) (TSX-V: CGLD, OTCQX: […]Read More
0 TSX Venture News - January 13, 2020Angkor Signs USD $4.6 Million Earn-In Agreement on Oyadao LicenseTORONTO, Jan. 13, 2020 (GLOBE NEWSWIRE) — Angkor Resources Corp. (TSXV: ANK and OTC: ANKOF) (“Angkor” or “the Company”) CEO […]Read More
0 TSX Venture News - January 13, 2020VitalHub Continues Expansion of the B Care EHR Platform in the Province of Manitoba With a Sale to Eden Health Care ServicesTORONTO, Jan. 13, 2020 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that […]Read More
0 TSX Venture News - January 13, 2020Giyani Accompanies SRK, Tetra Tech and Royal IHC on a Site Visit to its K.Hill Manganese Deposit in Botswana to Kick off Feasibility StudyNot for distribution to U.S. newswire services or for dissemination in the United StatesOAKVILLE, Ontario, Jan. 13, 2020 (GLOBE NEWSWIRE) […]Read More
0 TSX Venture News - January 13, 2020BriaCell Provides Update on Remarkable ResponderPatient initially identified September 19, 2019 as a Remarkable Responder;Patient has continued to experience a highly remarkable reduction in tumors […]Read More
0 TSX Venture News - January 13, 2020Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPreReports 30.5% and 36.7% reduction in triglyceride levels, compared with baseline, among patients receiving CaPre at 12 and 26 weeks […]Read More
0 TSX Venture News - January 13, 2020Search Closes Flow Through Private Placement and Shares for Debt Transaction and Extends Convertible DebentureVANCOUVER, British Columbia, Jan. 13, 2020 (GLOBE NEWSWIRE) — Search Minerals Inc. (TSXV: SMY) (“Search” or the “Company”) is pleased […]Read More
0 TSX Venture News - January 13, 2020Athabasca Minerals Inc. Updates Duvernay & Montney Joint-Venture ProjectsEDMONTON, Alberta, Jan. 13, 2020 (GLOBE NEWSWIRE) — Athabasca Minerals Inc. (“AMI” or the “Corporation”) – TSX Venture symbol: ‘AMI’ […]Read More